心臓弁装置の市場：タイプ別、エンドユーザー別-2025-2030年の世界予測

心臓弁装置市場は、2023年に79億6,000万米ドルと評価され、2024年には87億4,000万米ドルに達すると予測され、CAGR 9.90％で成長し、2030年には154億2,000万米ドルに達すると予測されています。

心臓弁装置市場には、主に僧帽弁、大動脈弁、肺動脈弁、三尖弁を中心に、心臓の天然弁の機能を再現するように設計された医療機器が含まれます。これらの医療機器は、人口の高齢化と生活習慣に関連した心血管疾患の有病率の上昇に起因する心臓弁障害の発生率の上昇のために非常に重要です。欠陥のある心臓弁を交換または修復するための外科手術や低侵襲手術に適用され、患者の余命と質を向上させる。エンドユーザーは病院、外来手術センター、専門クリニックなど多岐にわたる。市場成長の大きな原動力は、経カテーテル弁置換／修復技術のような技術的進歩、ヘルスケア支出の増加、旺盛な研究開発投資です。世界人口の高齢化と低侵襲手術の急増は、心臓弁装置の採用拡大に有利な機会を生み出しています。さらに、主要企業間の戦略的提携や買収が技術革新と市場拡大を促進すると予想されています。しかし、厳しい規制の枠組み、潜在的な機器の不具合、高額な機器コストなどの課題が成長を阻害する可能性があります。限界としては、外科手術による合併症のリスクや、世界的に異なる償還シナリオなどが挙げられます。このようなハードルにもかかわらず、バルブの長寿命化のための生体適合性材料、患者に特化したデバイスのカスタマイズのためのAIの進歩、手技結果を改善する経カテーテルバルブ技術の開発など、技術革新の機が熟した分野が数多く存在します。バルブの耐久性向上、術後合併症の軽減、低侵襲手技のためのデリバリーシステムの改良に焦点を当てた調査は、市場ポジションを強化することができます。激しい競合と急速な技術進化を特徴とする市場は、製品ラインナップの統合と地理的範囲の拡大に向けられています。市場シェアの獲得を目指す企業は、戦略的提携、絶え間ないイノベーション、消費者の認知度を高める積極的なマーケティング戦略、ヘルスケア・インフラが整備されつつある新興市場への投資を優先すべきです。

市場力学：急速に進化する心臓弁装置市場の主要市場インサイトを公開

心臓弁装置市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 弁膜症の高い発生率と相まって、世界の老人人口の急増
  • 弁膜症の正確な診断に向けた高度な計算ツールの利用可能性の高まり
  • 最小侵襲手技へのシフトとヘルスケア支出の増加
• 市場抑制要因
  • 治療に伴う合併症
  • 製造コストがかかるため、比較的高価な装置
• 市場機会
  • バルブのカスタマイズによる技術の進歩
  • 有利な償還政策と政府研究費の増加
• 市場の課題
  • 複雑な規制手続きによる製品承認の問題

ポーターの5つの力：心臓弁装置市場をナビゲートする戦略ツール

ポーターの5つの力」フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：心臓弁装置市場における外部からの影響の把握

外部マクロ環境要因は、心臓弁装置市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析心臓弁装置市場における競合情勢の把握

心臓弁装置市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス心臓弁装置市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、心臓弁装置市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨心臓弁装置市場における成功への道筋を描く

心臓弁装置市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で高齢者人口が急増し、弁膜疾患の発生率も上昇
    • 弁膜疾患の正確な診断に向けた高度な計算ツールの利用可能性の拡大
    • 低侵襲手術への移行とヘルスケア費の増加
  • 抑制要因
    • 治療に伴う合併症
    • 製造コストが高いため、比較的高価なデバイス
  • 機会
    • バルブのカスタマイズによる技術の進歩
    • 有利な償還政策と調査に対する政府資金の増加
  • 課題
    • 複雑な規制手続きによる製品承認の問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 心臓弁装置の市場：タイプ別

• 生物学的心臓弁
  • 大動脈弁
  • 僧帽弁
  • 肺動脈弁
  • 三尖弁
• 人工心臓弁
  • 大動脈弁
  • 僧帽弁
• 経カテーテル心臓弁
  • 大動脈弁
  • 僧帽弁
  • 肺動脈弁

第7章 心臓弁装置の市場：エンドユーザー別

• 外来手術センター
• 病院

第8章 南北アメリカの心臓弁装置の市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の心臓弁装置の市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの心臓弁装置の市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Boston Scientific Corporation
• CryoLife, Inc.
• Edward Lifesciences Corporation
• JenaValve Technology, Inc.
• Medtronic
• Micro Interventional Devices
• Neovasc, Inc.
• Sorin Group
• Symetis SA

LIST OF FIGURES

• FIGURE 1. HEART VALVE DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. HEART VALVE DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HEART VALVE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. HEART VALVE DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. HEART VALVE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HEART VALVE DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HEART VALVE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HEART VALVE DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AORTIC VALVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MITRAL VALVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PULMONARY VALVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TRICUSPID VALVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AORTIC VALVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MITRAL VALVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AORTIC VALVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MITRAL VALVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PULMONARY VALVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 42. CANADA HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. CANADA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 44. CANADA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 45. CANADA HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 46. CANADA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. CHINA HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. CHINA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 71. CHINA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 72. CHINA HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 73. CHINA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. INDIA HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. INDIA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 76. INDIA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 77. INDIA HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 78. INDIA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 160. ITALY HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 161. ITALY HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 162. ITALY HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 163. ITALY HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 164. ITALY HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 180. POLAND HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 181. POLAND HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 182. POLAND HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 183. POLAND HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 184. POLAND HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 185. QATAR HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 186. QATAR HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 187. QATAR HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 188. QATAR HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 189. QATAR HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 235. HEART VALVE DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 236. HEART VALVE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Heart Valve Devices Market was valued at USD 7.96 billion in 2023, expected to reach USD 8.74 billion in 2024, and is projected to grow at a CAGR of 9.90%, to USD 15.42 billion by 2030.

The heart valve devices market encompasses medical devices designed to replicate the function of the heart's natural valves, primarily focusing on mitral, aortic, pulmonary, and tricuspid valves. These devices are crucial due to rising incidences of heart valve disorders stemming from an aging population and increasing prevalence of lifestyle-related cardiovascular diseases. They are applied in surgical and minimally-invasive procedures to replace or repair faulty heart valves, enhancing patient life expectancy and quality. End-users span across hospitals, ambulatory surgical centers, and specialty clinics. Market growth is significantly driven by technological advancements like transcatheter valve replacement/repair technologies, rising healthcare expenditure, and robust R&D investments. An aging global population and a surge in minimally invasive surgeries are creating lucrative opportunities for increased adoption of heart valve devices. Furthermore, strategic partnerships and acquisitions among key players are anticipated to foster innovation and market expansion. However, challenges such as stringent regulatory frameworks, potential device malfunctions, and high device costs can impede growth. Limitations include the risk of complications from surgical procedures and varying reimbursement scenarios globally. Despite these hurdles, there are numerous areas ripe for innovation such as biocompatible materials for valve longevity, advancements in AI for patient-specific device customization, and developments in transcatheter valve technologies improving procedural outcomes. Research focusing on enhancing valve durability, reducing post-surgical complications, and improving delivery systems for minimally invasive techniques can reinforce market positions. The market, characterized by intense competition and rapid technological evolution, is directed towards consolidating product offerings and expanding geographic reach. Businesses aiming to capture market share should prioritize strategic alliances, continuous innovation, aggressive marketing strategies to enhance consumer awareness, and investments in emerging markets with growing healthcare infrastructures.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Heart Valve Devices Market

The Heart Valve Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Surge in geriatric population globally coupled with high incidence of valvular diseases
  • Growing availability of advanced computational tools toward accurate diagnosis of valvular disease
  • Shift towards minimal invasive procedures and increasing healthcare expenditure
• Market Restraints
  • Complications associated to the treatment
  • Relatively expensive device due to extensive manufacturing cost
• Market Opportunities
  • Technological advancements with customization of valves
  • Favourable reimbursement policies and increased government funding for research
• Market Challenges
  • Issues with product approval owing to complex regulatory procedures

Porter's Five Forces: A Strategic Tool for Navigating the Heart Valve Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Heart Valve Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Heart Valve Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Heart Valve Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Heart Valve Devices Market

A detailed market share analysis in the Heart Valve Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Heart Valve Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Heart Valve Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Heart Valve Devices Market

A strategic analysis of the Heart Valve Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Heart Valve Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Boston Scientific Corporation, CryoLife, Inc., Edward Lifesciences Corporation, JenaValve Technology, Inc., Medtronic, Micro Interventional Devices, Neovasc, Inc., Sorin Group, and Symetis SA.

Market Segmentation & Coverage

This research report categorizes the Heart Valve Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Biological Heart Valves, Mechanical Heart Valves, and Transcatheter Heart Valves. The Biological Heart Valves is further studied across Aortic Valves, Mitral Valves, Pulmonary Valves, and Tricuspid Valves. The Mechanical Heart Valves is further studied across Aortic Valves and Mitral Valves. The Transcatheter Heart Valves is further studied across Aortic Valves, Mitral Valves, and Pulmonary Valves.
• Based on End User, market is studied across Ambulatory Surgical Centers and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Surge in geriatric population globally coupled with high incidence of valvular diseases
    • 5.1.1.2. Growing availability of advanced computational tools toward accurate diagnosis of valvular disease
    • 5.1.1.3. Shift towards minimal invasive procedures and increasing healthcare expenditure
  • 5.1.2. Restraints
    • 5.1.2.1. Complications associated to the treatment
    • 5.1.2.2. Relatively expensive device due to extensive manufacturing cost
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements with customization of valves
    • 5.1.3.2. Favourable reimbursement policies and increased government funding for research
  • 5.1.4. Challenges
    • 5.1.4.1. Issues with product approval owing to complex regulatory procedures
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Heart Valve Devices Market, by Type

• 6.1. Introduction
• 6.2. Biological Heart Valves
  • 6.2.1. Aortic Valves
  • 6.2.2. Mitral Valves
  • 6.2.3. Pulmonary Valves
  • 6.2.4. Tricuspid Valves
• 6.3. Mechanical Heart Valves
  • 6.3.1. Aortic Valves
  • 6.3.2. Mitral Valves
• 6.4. Transcatheter Heart Valves
  • 6.4.1. Aortic Valves
  • 6.4.2. Mitral Valves
  • 6.4.3. Pulmonary Valves

7. Heart Valve Devices Market, by End User

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centers
• 7.3. Hospitals

8. Americas Heart Valve Devices Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Heart Valve Devices Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Heart Valve Devices Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Boston Scientific Corporation
• 3. CryoLife, Inc.
• 4. Edward Lifesciences Corporation
• 5. JenaValve Technology, Inc.
• 6. Medtronic
• 7. Micro Interventional Devices
• 8. Neovasc, Inc.
• 9. Sorin Group
• 10. Symetis SA